- How To
- Cigar Info
- Site Info
Currently viewing the tag: "labels-lights"
The FDA issued six new warning statements for cigar packaging and advertisements and a new nicotine addictiveness warning statement for pipe tobacco. The statements were issued as part of the FDA’s deeming regulations, which extended the agency’s tobacco
This guidance document is intended to assist any person who manufactures, packages, sells, offers to sell, distributes, or imports cigars or pipe tobacco with respect to the labeling requirements in sections 903(a)(2) and 920(a) of the Federal Food, Dr
This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies
This webinar provides information for retailers about a new warning statement that is required in 2018 on certain tobacco product packing and advertisements. Additional tobacco compliance webinars can be found on our website.
FDA has provided a compliance date of August 10, 2018, for the required health warning statements on packages and advertisements for “covered” tobacco products (except cigars and pipe tobacco1) and roll-your-own / cigarette tobacco products.2
As more local governments consider tobacco flavor bans like the one upheld by San Francisco voters in early June, tobacco companies are increasingly labeling flavored little cigars and other tobacco products with names that are ambiguous and non-descript
congratulates President Tabaré Vázquez of Uruguay on his presidential decree of August 6 mandating that tobacco products be sold in plain packaging. The decree, which overcomes parliamentary inaction, maintains health warnings covering 80 percent of tobac
tobacco companies are increasingly labeling flavored little cigars and other tobacco products with names that are ambiguous and non-descriptive to get around these restrictions, CDC researchers report. They found that between 2012 and 2016, cigar sales i
The public comment periods for all three ANPRMs, which were extended by 30 additional days to allow more time for submissions, have now closed. We are beginning the process of reviewing those comments. At the same time, the FDA is also pursuing additional
product innovations, such as flavour capsule variants (FCVs), remain unregulated…Policy makers should disallow FCV innovations, which offer no health benefits to smokers and may instead attract non-smokers to smoking. Where timely, these regulations cou